Christoph Wulf

Christoph Wulf is a seasoned professional in the pharmaceutical and biotechnology industries, currently serving as Vice President and Head of Commercial at Nielsen BioSciences, Inc. Since October 2023, Christoph has focused on developing the US commercial organization for the company's first Phase III asset, emphasizing forecast, reimbursement, and provider economics. Prior to this role, Christoph was an Independent Strategy Consultant and held significant positions at LEO Pharma, where as Executive Director, Christoph redirected marketing strategy for atopic dermatitis biologics, and at Moderna, where Christoph led the marketing launch for the COVID-19 vaccine. Experience also includes pivotal roles at Sanofi Genzyme, creating new marketing functions and leading commercial strategies for product launches. Christoph holds an MBA in Marketing Management from Thunderbird School of Global Management, where academic achievements included graduating with honors.